-
Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications
25 Sep 2025 14:07 GMT
… luteolin was designed for prostate cancer cells. This inhibitor mixture … (Figure 2D).58 Paclitaxel was developed by functionalizing … (Figure 4B).68 In prostate cancer, a tumor microenvironment (TME … proteins in mice bearing prostate tumor. Colloids Surf B. …
-
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
18 Jul 2025 12:27 GMT
… delivering stronger epigenetic effects than Paclitaxel or Rapamycin in aggressive PC3 … in aggressive human prostate cancer cells-achieving greater efficacy than Paclitaxel and Rapamycin …
-
Engineering Study on Targeted Therapy of Osteosarcoma Using Tripterine Loaded Polydopamine Mesoporous Microspheres Combined with Photothermal Therapy
24 Sep 2025 09:50 GMT
… , melanoma, pancreatic cancer, lung cancer, prostate cancer, breast cancer, and colorectal cancer … . Multifunctional mesoporous polydopamine with hydrophobic paclitaxel for photoacoustic imaging-guided chemo …
-
Hepatotoxicity of Nanoparticle-Based Anti-Cancer Drugs: Insights into Toxicity and Mitigation Strategies
23 Sep 2025 08:49 GMT
… colon,88 breast,89 prostate cancer,90 and melanoma.91 … on the premedication of paclitaxel liposome in the treatment … al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer … co-encapsulated resveratrol and paclitaxel in liposomes for drug …
-
Investornewsbreaks Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success Of Telomir-1 In Prostate Cancer Model
19 Mar 2025 19:46 GMT
… by approximately 50% in a prostate cancer animal model. The study demonstrated … -induced toxicity when combined with Paclitaxel. Contrary to concerns that telomere …
-
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
19 Mar 2025 11:56 GMT
… by approximately 50% in a prostate cancer animal model with aggressive cancer … and mortality when combined with Paclitaxel—a widely used chemotherapy but … For Antibacterial Treatment, Tissue Regeneration
Paclitaxel and other chemotherapy agents induce …
-
<![CDATA[Five Under 5: Top Oncology Videos for the Week of 9/14]]>
21 Sep 2025 13:37 GMT
… sat down with OncLive during Prostate Cancer Awareness Month to discuss factors … (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with … for evaluating relacorilant plus nab-paclitaxel (Abraxane) for the treatment …
-
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
01 Feb 2025 10:18 GMT
… prostate tumors in the bone microenvironment. Mesenchymal stem cells induce already disseminated prostate cancer … facilitating metastatic prostate tumor growth in … stem cells into prostate tumours promotes metastasis. … inhibitor, and paclitaxel in patients …
-
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets
28 Apr 2025 17:19 GMT
… eribulin, capecitabine and paclitaxel (Figure 2A). Plasma … and phosphatidylcholines with Paclitaxel treatment (Figure 4C … eribulin, capecitabine and paclitaxel, respectively. Metabolically, … carboxylate released by prostate cancer cell inhibit T …
-
AstraZeneca’s Truqap Redeems Itself with Phase III Prostate Cancer Win
26 Nov 2024 12:49 GMT
… de novo metastatic hormone-sensitive prostate cancer.
Data for overall survival ( … trial, which combined Truqap with paclitaxel, found no significant OS benefit … patients with metastatic castration-resistant prostate cancer (mCRPC) versus Xtandi alone. These …
About
© 1995-2025